TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $82,000 | – | 33,880 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 392,952 | $4,051,000 | 0.53% |
| BLUESTEIN R H & CO LLC | 179,800 | $1,854,000 | 0.12% |
| Edge Wealth Management LLC | 15,000 | $154,000 | 0.07% |
| Tower Research Capital LLC (TRC) | 1,316 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 37,190 | $384,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 100 | $1,000 | 0.00% |
| UBS AG | 1,878 | $19,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 106 | $1,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 2,500 | $25,000 | 0.00% |
| CREDIT SUISSE AG/ | 19,370 | $200,000 | 0.00% |